BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10534334)

  • 1. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection.
    Sebagh M; Debette M; Samuel D; Emile JF; Falissard B; Cailliez V; Shouval D; Bismuth H; Reynès M
    Hepatology; 1999 Nov; 30(5):1144-50. PubMed ID: 10534334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venular stenosis after orthotopic liver transplantation.
    Dhillon AP; Burroughs AK; Hudson M; Shah N; Rolles K; Scheuer PJ
    Hepatology; 1994 Jan; 19(1):106-11. PubMed ID: 8276346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.
    Sebagh M; Azoulay D; Roche B; Hoti E; Karam V; Teicher E; Bonhomme-Faivre L; Saliba F; Duclos-Vallée JC; Samuel D
    Liver Transpl; 2011 Jul; 17(7):798-808. PubMed ID: 21351239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
    Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Veno-occlusive disease after liver transplantation. Association of acute cellular rejection and toxicity of azathioprine].
    Mion F; Cloix P; Boillot O; Gille D; Bouvier R; Paliard P; Berger F
    Gastroenterol Clin Biol; 1993; 17(11):863-7. PubMed ID: 8143956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
    Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years.
    Kalayoglu-Besisik S; Yenerel MN; Caliskan Y; Ozturk S; Besisik F; Sargin D
    Transplant Proc; 2005 Jun; 37(5):2285-9. PubMed ID: 15964400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
    Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
    Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience.
    Górnicka B; Ziarkiewicz-Wróblewska B; Bogdańska M; Ołdakowska-Jedynak U; Wróblewski T; Morton M; Ziółkowski J; Paczek L; Krawczyk M; Wasiutyński A
    Transplant Proc; 2006; 38(1):221-5. PubMed ID: 16504708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection.
    Demirhan B; Bilezikçi B; Haberal AN; Sevmiş S; Arat Z; Haberal M
    Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
    Ozkaynak MF; Weinberg K; Kohn D; Sender L; Parkman R; Lenarsky C
    Bone Marrow Transplant; 1991 Jun; 7(6):467-74. PubMed ID: 1908340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
    Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
    Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A; Kobayashi R; Yoshida M; Kobayashi K; Matsuo K; Kitajima I; Maruyama I
    Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.
    Takamura H; Nakanuma S; Hayashi H; Tajima H; Kakinoki K; Kitahara M; Sakai S; Makino I; Nakagawara H; Miyashita T; Okamoto K; Nakamura K; Oyama K; Inokuchi M; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Onishi I; Kayahara M; Tani T; Arai K; Yamashita T; Yamashita T; Kitamura H; Ikeda H; Kaneko S; Nakanuma Y; Matsui O; Ohta T
    Transplant Proc; 2014 Dec; 46(10):3523-35. PubMed ID: 25498084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients.
    Sundaram SS; Melin-Aldana H; Neighbors K; Alonso EM
    Liver Transpl; 2006 Jan; 12(1):58-64. PubMed ID: 16382471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevant histopathologic findings that distinguish acute cellular rejection from cholangitis in hepatic allograft biopsy specimens.
    Bilezikçi B; Demirhan B; Kocbiyik A; Arat Z; Haberal M
    Transplant Proc; 2008; 40(1):248-50. PubMed ID: 18261599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode.
    Lovell MO; Speeg KV; Halff GA; Molina DK; Sharkey FE
    Liver Transpl; 2004 Mar; 10(3):369-73. PubMed ID: 15004763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.
    Simon M; Hahn T; Ford LA; Anderson B; Swinnich D; Baer MR; Bambach B; Bernstein SH; Bernstein ZP; Czuczman MS; Slack JL; Wetzler M; Herzig G; Schriber J; McCarthy PL
    Bone Marrow Transplant; 2001 Mar; 27(6):627-33. PubMed ID: 11319593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.
    Kami M; Mori S; Tanikawa S; Akiyama H; Onozawa Y; Tanaka T; Okamoto R; Maeda Y; Sasaki T; Kaku H; Matsuura Y; Hiruma K; Sakamaki H
    Bone Marrow Transplant; 1997 Sep; 20(5):397-402. PubMed ID: 9339756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma.
    Horn B; Reiss U; Matthay K; McMillan A; Cowan M
    Bone Marrow Transplant; 2002 Mar; 29(5):409-15. PubMed ID: 11919731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.